Question 1

What is the catalog number for Tissue FFPE Sections, Ureter?

Accepted Answer

The catalog number for Tissue FFPE Sections, Ureter is CS800240.

Question 2

What sizes are available for Tissue FFPE Sections, Ureter?

Accepted Answer

Tissue FFPE Sections, Ureter is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Ureter in stock?

Accepted Answer

Tissue FFPE Sections, Ureter is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Ureter?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Ureter is available here: https://cdn.origene.com/sds/cs800240.pdf.

Question 5

What is Tissue FFPE Sections, Ureter used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Ureter; Within normal limits

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 7

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 8

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Tissue FFPE Sections, Ureter

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Cadherin 17 / LI Cadherin (Liver-Intestine Marker) (CDH17/2616), CF568 conjugate, 0.1mg/mL

MYLC2PL (MYL10) Human Gene Knockout Kit (CRISPR)

Glycine max Gel -SBA- Immobilized Lectin

Bcl-2 (100/D5 + 124), CF740 conjugate, 0.1mg/mL

Recombinant OR1A1 Antibody

Recombinant OR1A1 Antibody